Practicum Journal: Safe Prescribing

There is probably no greater responsibility that the psychiatric mental health nurse practitioner (PMHNP) assumes than the responsibility of prescribing medications. While someone can be harmed by psychotherapy, the level and intensity of the harm generally does not come to the same level of harm that can occur from improper prescribing. The PMHNP must understand his/her responsibility both at a state and federal level when it comes to prescribing medications.

In this Practicum Journal Assignment, you will explore the legalities associated with prescribing controlled substances, as well as what a DEA number is, how to obtain one, and, most importantly, how to prescribe controlled substances in your state. 

Learning Objectives

· Analyze roles of the Drug Enforcement Administration

· Analyze PMHNP responsibilities when issued a DEA number

· Analyze DEA number application procedures

· Analyze state requirements for safe prescribing and prescription monitoring

· Analyze PMHNP responsibilities for safe prescribing and prescription monitoring

· Analyze Schedule II-V drug levels

                                        ASSIGNMENT

To prepare for this Practicum Journal:

· Review the Learning Resources.

In 2-3 pages:

· Describe the role of the Drug Enforcement Administration (DEA) as it pertains to 

the Psychiatric mental health nurse practitioner (PMHNP).

· Explain your responsibilities when having a DEA number.

· Explain how you apply for a DEA number.

· Explain your state’s requirements (TEXAS) for a safe prescribing and prescription monitoring program. Explain your responsibility as a PMHNP to follow these requirements.

· Provide an example of a drug you may prescribe from each of the Schedule II-V drug levels.

N: B PLEASE INCLUDE INTRODUCTION, CONCLUSION AND REFERENCES LESS THAN 5 YEARS OLD

                                                            Learning Resources

Required Readings

Stahl, S. M. (2014). Prescriber’s Guide: Stahl’s Essential Psychopharmacology (5th ed.). New York, NY: Cambridge University Press.

http://ezp.waldenulibrary.org/login?url=http://stahlonline.cambridge.org/ 

To access information on specific medications, click on The Prescriber’s Guide, 5th Ed. tab on the Stahl Online website and select the appropriate medication.

   

Depression

Premenstrual    dysphoric disorder

Seasonal    affective disorder (MDD with Seasonal Variation)

 

agomelatine
  amisulpride
  amitriptyline
  amoxapine
  amphetamine (d)
  amphetamine (d,l)
  aripiprazole (adjunct)
  asenapine
  atomoxetine
  bupropion
  buspirone (adjunct)
  citalopram
  clomipramine
  cyamemazine
  desipramine
  desvenlafaxine
  dothiepin
  paroxetine
  phenelzine
  protriptyline

quetiapine (adjunct)
  reboxetine
  selegiline
  sertindole
  sertraline
  sulpiride
  tianeptine
  tranylcypromine
  triiodothyronine
  trazodone
  trimipramine
  venlafaxine
  vilazodone
  vortioxetine
  doxepin
  duloxetine
  escitalopram
  fluoxetine
  flupenthixol
  fluvoxamine

iloperidone
  imipramine
  isocarboxazid
  ketamine
  lisdexamfetamine
  lithium (adjunct)
  l-methylfolate (adjunct)
  lofepramine
  lurasidone
  maprotiline
  methylphenidate (d)
  methylphenidate (d,l)
  mianserin
  milnacipran
  mirtazapine
  moclobemide
  modafinil (adjunct)
  nefazodone
  nortriptyline
  olanzapine

citalopram
  desvenlafaxine
  escitalopram
  fluoxetine
  paroxetine
  sertraline
  venlafaxine

bupropion

        

Drug Enforcement Administration. (n.d.). Drug schedules. Retrieved June 14, 2016, from https://www.dea.gov/druginfo/ds.shtml